Drugs / Cultured Thymus Tissue
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00576836 | Sep 2004 → Nov 2010 | DiGeorge syndrome | Sumitomo Pharma Switzerland GmbH | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01220531 | Dec 2010 → Aug 2023 | DiGeorge syndrome | Sumitomo Pharma Switzerland GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultured Thymus Tissue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00576836 ↗ |
| Route | Intramuscular | “Cultured thymus tissue was implanted into quadriceps.” NCT00576836 ↗ |